bibliographic entry 12868264 [be/12868264]
https://w3id.org/oc/corpus/be/12868264

is a
content
  • Siu, LL, Shapiro, JD, Jonker, DJ, Karapetis, CS, Zalcberg, JR, Simes, J, Couture, F, Moore, MJ, Price, TJ, Siddiqui, J, Nott, LM, Charpentier, D, Liauw, W, Sawyer, MB, Jefford, M, Magoski, NM. Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type K-RAS colorectal carcinoma: the NCIC Clinical Trials Group and AGITG, CO.20 Trial, J Clin Oncol, 2013, 31, 2477, 2484, PMID: 23690424
references